Type 2 diabetes mellitus in Augsburg - An epidemiological overview

Gesundheitswesen

Volumn 67, Issue SUPPL. 1, 2005, Pages

  Meisinger, Christa ^a,b   Doring A ^b   Heier, M ^b   Thorand, B ^b   Lowel H ^a,b  

^a KLINIKUM AUGSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Diabetes mellitus; Epidemiology; Prevalence; Risk factors; Trends

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; CARDIOVASCULAR DISEASE; EXERCISE; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY PREVENTION; PUBLIC HEALTH; REGISTER; REVIEW; RISK FACTOR; SMOKING; WEIGHT REDUCTION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE PREDISPOSITION; ORAL GLUCOSE TOLERANCE TEST; PROGNOSIS; SEX DIFFERENCE;

ADULT; AGED; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; INCIDENCE; INTERNATIONALITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 23844464069     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858251     Document Type: Review

References (33)

1. Resnick HE, Shorr RI, Kuller L et al. Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults. J Clin Epidemiol 2001; 54: 869-876
2. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-268
3. Feskens EJ, Kromhout D. Glucose tolerance and the risk of cardiovascular disease: the Zutphen Study. J Clin Epidemiol 1992; 45: 1327-1334
4. Haffner SM, Lehto S, Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
5. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993; 88: 837-845
6. Fabris F, Zanocchi M, Bo M et al. Carotid plaque, aging, and risk factors. Stroke 1994; 25: 1133-1140
7. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in U.S. adults. JAMA 1999; 281: 1291-1297
8. Illig T, Bongardt F, Schöpfer A et al. Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 5053-5058
9. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431
10. Keil U, Liese AD, Hense HW et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Eur Heart J 1998; 19: 1197-1207
11. Hense HW, Filipiak B, Döring A et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany. Results from the 1984/85,1989/90, and 1994/95 surveys. CVD Prevention 1998; 1: 318-327
12. Holle R, Happich M, Löwel H et al. KORA - A research platform for population based health research. Gesundheitswesen 2005; 67 S1: S19-S25
13. Löwel H, Meisinger C, Heier M et al. The population-based Acute Myocardial Infarction (AMI) Registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen 2005; 67 S1: S31-S37
14. Diamond J. The double puzzle of diabetes. Nature 2003; 423: 599-602
15. Katsilambros N, Aliferis K, Darviri C et al. Evidence for an increase in the prevalence of known diabetes in a sample of an urban population in Greece. Diabet Med 1993; 10: 87-90
16. Neil HA, Gatling W, Mather HM et al. The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med 1987; 4: 539-543
17. Laakso M, Reunanen A, Klaukka T et al. Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am J Epidemiol 1991; 133: 850-857
18. Meisinger C, Heier M, Doering A et al. Prevalence of known diabetes and antidiabetic therapy between 1984/85 and 1999/2001 in Southern Germany. Diabetes Care 2004; 27: 2985-2987
19. Thefeld W. Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands. Gesundheitswesen 1999; 61: 85-S89
20. Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189
21. Rathmann W, Haastert B, Icks A et al. The diabetes epidemic in the elderly population in Western Europe: data from population-based studies. Gesundheitswesen 2005; 67 S1: S110-S114
22. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350
23. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
24. Haffner SM, Stern MP, Hazuda HP et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before onset of clinical diabetes? JAMA 1990; 263: 2893-2898
25. Meisinger C, Thorand B, Schneider A et al. Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 2002; 162: 82-89
26. Pearson TA, Blair SN, Daniels SR et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation 2002; 106: 388-391
27. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-1610
28. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
29. Riddle M. Combining sulfonylureas and other oral agents. Am J Med 2000; 108: 15-22
30. Löwel H, Koenig W, Engel S et al. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 2000; 43: 218-226
31. Löwel H, Stieber J, Koenig W et al. The diabetes-related risk of acute myocardial infarction in a southern German population: Results of the MONICA-Augsburg-studies 1985-1994. Diab Stoffw 1999; 8: 11-21
32. Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004; 44: 397-405
33. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762